NS Materials

About NS Materials

NS Materials Inc. is a Japanese firm established on May 23, 2006, that has pivoted its focus towards the precision equipment sector, with a specialization in medical devices. The company was founded by Eiichi Kanamori, who previously gained experience in business systems and ISO certification at a biotech research equipment manufacturer before delving into micro-space chemical technology. This background in microfluidics and an encounter with the National Institute of Advanced Industrial Science and Technology's (AIST) research into synthesizing nanomaterials using this technology sparked the venture. Initially launched as an AIST technology transfer venture, the company first engaged in contract-based technology development.

A significant shift occurred in August 2023 when NS Materials transferred its nano-materials business, including its quantum dot nano-phosphor development, to TOPPAN Inc. This strategic move allowed the company to concentrate its resources on the development, manufacturing, and sales of medical devices and systems, alongside equipment for the biotechnology, semiconductor, and ICT sectors. The company operates its own ISO 13485 certified factory, enabling flexible production schedules and adherence to quality standards for both medical and veterinary devices. NS Materials' business model now revolves around providing comprehensive services from design and development to mass production of precision equipment, including OEM manufacturing.

The company's history includes several key milestones, such as receiving the "AIST Technology Transfer Venture" title in August 2006 and obtaining its medical device manufacturing license in October 2007. It secured multiple rounds of venture capital funding and in March 2017, raised a significant ¥750 million from investors including Nissay Capital and The University of Tokyo Edge Capital. This capital supported the growth of its former nano-materials division, which was focused on producing quantum dots for the 4K television market. Following the 2023 business transfer, the company has streamlined its operations to specialize in the medical and precision instrument fields, leveraging its extensive experience in product development and manufacturing.